A Phase II Trial Comparing Dalpiciclib in Combination with Letrozole Versus Standard Chemotherapy As Neoadjuvant Therapy in Patients with High-Risk HR- Positive HER-2 Negative Breast Cancer: DARLING-02.
JOURNAL OF CLINICAL ONCOLOGY(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要